Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.
- Home
- Clinical Trials
Atopic Dermatitis Studies Sydney DH 62
Atopic Dermatitis Study
Darlinghurst Sydney
Please note that this study has now closed. However, we encourage you to pre-register your interest for future atopic dermatitis studies here.
Description
What to expect
Study details
Ages
18 to 75 years of age
Duration
The study has a duration of approximately 77 weeks and involves up to 24 in clinic visits
Compensation
Participants will be compensated up to $6,185
Eligibility Criteria
You may qualify if you:
- Are 18 to 75 years of age
- Have moderate to severe eczema affecting at least 10% of your body
- Have had eczema for at least 3 years
- Have eczema that cannot be adequately controlled with topical medications (or if you are unable to use topical treatments)
Other criteria applies. A member of our team will check if this study is a good fit for you.
Locations
Description
Atopic Dermatitis also called eczema is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.
Flare ups of symptoms can be caused by a wide range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it hard for your skin to keep moisture in, and allows for allergens and irritant to pass more easily through your skin.
There are some treatments approved for eczema, but not everyone responds to them and some patients may not be able to take the existing medications.
This study is investigating an investigational oral medicine that targets a key immune pathway involved in eczema inflammation.
Researchers are evaluating whether this treatment can:
- Reduce eczema severity and itching
- Improve skin health and comfort
- Enhance quality of life for people living with eczema
What to expect
Participants will be randomly assigned to take two oral tablets once daily for 16 weeks. The tablets will contain either the investigational treatment or a placebo (inactive substance). After this period, all participants who continue in the study will receive the investigational treatment during a 52-week open label treatment period so researchers can further assess its effects.
You’ll attend regular clinic visits for skin assessments, blood tests and study related health checks. Your safety and well-being will be closely monitored by a professional medical team throughout the study.
Why join this clinical research study?
- Gain early access to a potential oral eczema treatment at no cost
- Contribute to research that could improve the lives of others living with eczema
- Learn to better manage your condition
- Receive periodic study related health checks from our professional medical team at no cost
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future atopic dermatitis studies here.